A potential tumor-suppressive role mediated by mTOR pathway was attributed to miR-99a, since this miRNA has been shown to be strongly downregulated in renal cancer tissues and correlated with poor survival in RCC patients. This evidence concerns the gene MTOR and renal cell carcinoma.